NeuroPace, Inc. - NPCE

SEC FilingsOur NPCE Tweets

About Gravity Analytica

Recent News

  • 09.04.2025 - Cantor Global Healthcare Conference
  • 09.04.2025 - Cantor Global Healthcare Conference
  • 08.12.2025 - Q2 2025 NeuroPace Earnings Conference Call
  • 08.12.2025 - Q2 2025 NeuroPace Earnings Conference Call
  • 08.12.2025 - NeuroPace Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
  • 08.12.2025 - NeuroPace Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
  • 08.01.2025 - NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases
  • 08.01.2025 - NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases
  • 07.29.2025 - NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025
  • 07.29.2025 - NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025

Recent Filings

  • 09.03.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 08.28.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.28.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.22.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 08.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 08.12.2025 - EX-99.1 EX-99.1
  • 08.12.2025 - 8-K Current report
  • 08.05.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors